Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000878668 | SCV001021606 | benign | not provided | 2024-10-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004027912 | SCV004929719 | uncertain significance | Inborn genetic diseases | 2022-07-19 | criteria provided, single submitter | clinical testing | The c.4625C>T (p.P1542L) alteration is located in exon 48 (coding exon 48) of the COL4A5 gene. This alteration results from a C to T substitution at nucleotide position 4625, causing the proline (P) at amino acid position 1542 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003938397 | SCV004761116 | likely benign | COL4A5-related disorder | 2022-05-26 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |